Recombinant Rat FRS3 Protein

• Cat.No.: FRS3-2394R
• Product Overview: Recombinant Rat FRS3 full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Rat
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: Frs3 fibroblast growth factor receptor substrate 3 [ Rattus norvegicus ]
• Official Symbol: FRS3
• Gene ID: 316213
• mRNA Refseq: NM_001017382.1
• Protein Refseq: NP_001017382.1
• UniProt ID: Q52RG8

Reviews

01/13/2022

The FRS3 protein not only fulfills my experimental requirements but is also backed by excellent technical support, which guarantees a smooth and successful research experience.

07/15/2017

The manufacturer of the FRS3 protein plays a vital role in supporting my trials.

04/26/2017

By using the FRS3 protein in my experiments, I am confident in obtaining accurate and dependable data.

Q&As

How does FRS3 participate in immune system regulation, and what clinical applications does this have?

FRS3 is involved in immune response modulation, and understanding its function may lead to the development of immunotherapies or treatments for autoimmune disorders.

What clinical applications are associated with understanding FRS3's involvement in cancer?

Targeting FRS3 may provide a novel approach for cancer therapy, and assessing its levels could serve as a diagnostic and prognostic marker.

How does FRS3 protein contribute to neurological disorders, and what clinical implications does this have

FRS3 has been implicated in certain neurological disorders, and understanding its role may open avenues for therapeutic interventions in neurodegenerative diseases.

How is FRS3 protein implicated in cancer development?

FRS3 has been found to be overexpressed in certain cancers, suggesting a potential role in promoting tumor growth and progression.

Are there any ongoing clinical trials investigating FRS3 as a therapeutic target for cancer treatment?

Research is underway to explore the efficacy of FRS3-targeted therapies in clinical trials, evaluating its potential in cancer patients.